What is Arcturus Therapeutics Holdings Net Margin %?
Net margin is calculated as Net Income divided by its Revenue. Arcturus Therapeutics Holdings's Net Income for the
three
months ended in Dec. 2023 was $-11.7 Mil. Arcturus Therapeutics Holdings's Revenue for the
three
months ended in Dec. 2023 was $25.1 Mil. Therefore, Arcturus Therapeutics Holdings's net margin for the quarter that ended in Dec. 2023 was -46.68%.
The historical rank and industry rank for Arcturus Therapeutics Holdings's Net Margin % or its related term are showing as below:
ARCT'
s Net Margin % Range Over the Past 10 Years
Min: -1647.98 Med: -83.87 Max: 4.54
Current: -18.84
ARCT's Net Margin % is ranked better than 68.26% of 1027
companies
in the Biotechnology industry
Industry Median: -162.84
vs ARCT: -18.84
Arcturus Therapeutics Holdings Net Margin % Historical Data
The historical data trend for Arcturus Therapeutics Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Arcturus Therapeutics Holdings's Net Margin %
For the Biotechnology subindustry, Arcturus Therapeutics Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcturus Therapeutics Holdings's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arcturus Therapeutics Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Arcturus Therapeutics Holdings's Net Margin % falls into.
Arcturus Therapeutics Holdings Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Arcturus Therapeutics Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcturus Therapeutics Holdings (NAS:ARCT) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Arcturus Therapeutics Holdings Net Margin % Related Terms
Thank you for viewing the detailed overview of Arcturus Therapeutics Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Arcturus Therapeutics Holdings (Arcturus Therapeutics Holdings) Business Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARCT has been successfully added to your 